Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose
- PMID: 34965310
- DOI: 10.1111/all.14996
Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose
Comment on
-
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?Allergy. 2021 Jun;76(6):1617-1618. doi: 10.1111/all.14711. Allergy. 2021. PMID: 33320974 No abstract available.
References
REFERENCES
-
- Cabanillas B, Akdis C, Novak N. Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol? Allergy. 2021;76:1617-1618.
-
- Sellaturay P, Nasser S, Ewan P. Polyethylene glycol-induced systemic allergic reactions (Anaphylaxis). J Allergy Clin Immunol Pract. 2020;S2213-2198(20):31007-31012.
-
- Banerji A, Wickner PG, Saff R, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol Pract. 2021;9(4):1423-1437. https://doi.org/10.1016/j.jaip.2020.12.047
-
- Troelnikov A, Perkins G, Yuson C, et al. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in PEG allergic patients [published online ahead of print, 2021 May 12]. J Allergy Clin Immunol. 2021;S0091-6749(21):00731-734. https://doi.org/10.1016/j.jaci.2021.04.032
-
- Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130(1):25-43. https://doi.org/10.1016/j.jaci.2012.04.003. Epub 2012 May 16 PMID: 22608573.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
